Alumis Inc Asset Turnover Ratio (ALMS), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Alumis inc   (NASDAQ: ALMS)
 

Alumis Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the first quarter 2026, Alumis Inc 's asset turnover ratio sequentially decreased to 0.02 in the first quarter (Mar 31 2026), this is lower than usual.

Within sector 181 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2994 to 3660.

Asset Turnover Ratio Definition



ALMS Asset Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Asset Change 157.02 % 25.53 % 24.3 % 132.44 % 161.92 %
Y / Y Revenue Change -89.99 % - - - -
Asset Turnover Ratio (TTM) 0.02 0.05 0.05 0.05 0.06
ALMS's Total Ranking # 3660 # 2994 # 0 # 0 # 0
Seq. Asset Change 63.03 % -15.59 % -17.68 % 126.88 % -20.37 %
Seq. Revenue Change -9.75 % -6.63 % -22.51 % -84.67 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 182
Healthcare Sector # 531
Overall Market # 3660

Asset Turnover Ratio Statistics
High Average Low
0.05 0.03 0.02
(Dec 31 2025)   (Mar 31 2026)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Assets at quarter ending Mar 31 2026
Pluri Inc   0.03 $ 1.079  Millions$ 32.252  Millions
Vivos Inc  0.03 $ 0.078  Millions$ 2.472  Millions
Bioage Labs Inc   0.03 $ 10.316  Millions$ 329.945  Millions
Newamsterdam Pharma Company N v   0.03 $ 22.565  Millions$ 775.867  Millions
Tao Synergies Inc   0.03 $ 0.688  Millions$ 23.758  Millions
Dbv Technologies S a   0.03 $ 5.783  Millions$ 209.755  Millions
Northwest Biotherapeutics Inc  0.03 $ 1.497  Millions$ 55.374  Millions
Onkure Therapeutics Inc   0.03 $ 2.816  Millions$ 104.929  Millions
Atrium Therapeutics Inc   0.03 $ 36.817  Millions$ 1,438.386  Millions
Eyepoint Inc   0.03 $ 7.614  Millions$ 301.264  Millions
Mangoceuticals Inc   0.02 $ 0.415  Millions$ 16.978  Millions
Uniqure N v   0.02 $ 18.093  Millions$ 769.222  Millions
Co diagnostics Inc   0.02 $ 0.718  Millions$ 34.362  Millions
Anteris Technologies Global Corp   0.02 $ 1.851  Millions$ 94.168  Millions
Fate Therapeutics Inc   0.02 $ 6.316  Millions$ 329.789  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.680  Millions$ 37.381  Millions
Vistagen Therapeutics Inc   0.02 $ 1.269  Millions$ 70.690  Millions
Envoy Medical Inc   0.02 $ 0.234  Millions$ 14.115  Millions
Aim Immunotech Inc   0.02 $ 0.094  Millions$ 5.998  Millions
Alumis inc   0.02 $ 8.402  Millions$ 545.617  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 58.849  Millions
Entrada Therapeutics Inc   0.01 $ 5.738  Millions$ 393.644  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 18.069  Millions$ 1,253.296  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 2.526  Millions$ 176.533  Millions
Ataibeckley Inc   0.01 $ 3.488  Millions$ 246.656  Millions
Vyne Therapeutics Inc   0.01 $ 0.535  Millions$ 39.294  Millions
Medicinova Inc   0.01 $ 0.597  Millions$ 46.428  Millions
Prime Medicine Inc   0.01 $ 4.034  Millions$ 325.371  Millions
Vivosim Labs Inc   0.01 $ 0.131  Millions$ 10.925  Millions
Rafael Holdings Inc  0.01 $ 1.131  Millions$ 104.893  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.